The Zhitong Finance App learned that on June 10, the China Securities Regulatory Commission announced the progress of the “approval of overseas initial public offerings of shares (including common shares, preferred shares, etc., and derivative forms of stocks)” of Shandong Weigao Blood Purification Products Co., Ltd., which has now reached the stage of receiving materials.
证监会：山东威高血液净化制品股份有限公司境外IPO申请已获接收材料
Securities Regulatory Commission: Shandong Weigao Blood Purification Products Co., Ltd.'s overseas IPO application has received materials
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.